Nome |
# |
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza a(H1N1)pdm09 and B among elderly people in Europe: Results from the I-MOVE+ project, file e0feeaa7-9418-44d2-e053-6605fe0a8db0
|
196
|
A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses, file e0feeaa7-a192-44d2-e053-6605fe0a8db0
|
196
|
Egg-Independent Influenza Vaccines and Vaccine Candidates, file e0feeaa7-a088-44d2-e053-6605fe0a8db0
|
188
|
Immunogenicity and safety of the new inactivated quadrivalent influenza vaccine vaxigrip tetra: Preliminary results in children ≥6 months and older adults, file e0feeaa7-a194-44d2-e053-6605fe0a8db0
|
176
|
Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017, file e0feeaa8-6014-44d2-e053-6605fe0a8db0
|
167
|
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017, file e0feeaa8-a94c-44d2-e053-6605fe0a8db0
|
159
|
Influenza vaccines: Evaluation of the safety profile, file e0feeaa7-a1e3-44d2-e053-6605fe0a8db0
|
146
|
Emerging influenza strains in the last two decades: A threat of a new pandemic?, file e0feeaa7-a678-44d2-e053-6605fe0a8db0
|
144
|
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: Awareness warranted for 2017/18 season, file e0feeaa8-1766-44d2-e053-6605fe0a8db0
|
144
|
Influenza anti-stalk antibodies: Development of a new method for the evaluation of the immune responses to universal vaccine, file e0feeaa8-add9-44d2-e053-6605fe0a8db0
|
142
|
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza, file e0feeaa8-1767-44d2-e053-6605fe0a8db0
|
141
|
Single dose vaccination of the ASO3-adjuvanted A (H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains, file e0feeaa7-a250-44d2-e053-6605fe0a8db0
|
136
|
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions, file e0feeaa8-2bca-44d2-e053-6605fe0a8db0
|
135
|
Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy, file e0feeaa8-6015-44d2-e053-6605fe0a8db0
|
135
|
Age and influenza-specific pre-vaccination antibodies strongly affect influenza vaccine responses in the icelandic population whereas disease and medication have small effects, file e0feeaa7-a66c-44d2-e053-6605fe0a8db0
|
133
|
Live attenuated influenza vaccine in children induces b-cell responses in tonsils, file e0feeaa7-a674-44d2-e053-6605fe0a8db0
|
133
|
International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE, file e0feeaa7-a52a-44d2-e053-6605fe0a8db0
|
127
|
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies, file e0feeaa8-1768-44d2-e053-6605fe0a8db0
|
126
|
Pertussis over two decades: Seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy, file e0feeaa8-6413-44d2-e053-6605fe0a8db0
|
123
|
Measles in pregnancy: a threat for Italian women?, file e0feeaa8-a220-44d2-e053-6605fe0a8db0
|
123
|
Mapping host-related correlates of influenza vaccine-induced immune response: An umbrella review of the available systematic reviews and meta-analyses, file e0feeaa8-564e-44d2-e053-6605fe0a8db0
|
122
|
Overview of serological techniques for influenza vaccine evaluation: Past, Present and Future, file e0feeaa7-a24b-44d2-e053-6605fe0a8db0
|
115
|
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection, file e0feeaa8-a21f-44d2-e053-6605fe0a8db0
|
110
|
Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses, file e0feeaa7-f033-44d2-e053-6605fe0a8db0
|
97
|
Influenza immunology evaluation and correlates of protection: a focus on vaccines, file e0feeaab-be5c-44d2-e053-6605fe0a8db0
|
87
|
Immunogenicity Measures of Influenza Vaccines: A Study of 1164 Registered Clinical Trials, file e0feeaa8-ca7a-44d2-e053-6605fe0a8db0
|
72
|
Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014, file e0feeaa7-a1eb-44d2-e053-6605fe0a8db0
|
70
|
Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains, file e0feeaa9-5e04-44d2-e053-6605fe0a8db0
|
67
|
A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine, file e0feeaa5-9740-44d2-e053-6605fe0a8db0
|
66
|
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples, file e0feeaa9-818d-44d2-e053-6605fe0a8db0
|
66
|
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in tuscany, Italy, file e0feeaaa-5332-44d2-e053-6605fe0a8db0
|
60
|
Moderate vaccine effectiveness against severe acute respiratory infection caused by a(H1N1)pdm09 influenza virus and no effectiveness against a(H3N2) influenza virus in the 2018/2019 season in Italy, file e0feeaa9-434d-44d2-e053-6605fe0a8db0
|
58
|
null, file e0feeaa6-36f2-44d2-e053-6605fe0a8db0
|
56
|
Early rise of blood T follicular helper cell subsets and baseline immunity as predictors of persisting late functional antibody responses to vaccination in humans, file e0feeaa6-36f4-44d2-e053-6605fe0a8db0
|
54
|
Evaluation of varicella immunity during pregnancy in apulia region, southern italy, file e0feeaa9-76ca-44d2-e053-6605fe0a8db0
|
54
|
Seroprevalence of hepatitis e virus in forestry workers from trentino-alto adige region (Northern Italy), file e0feeaa9-2a8b-44d2-e053-6605fe0a8db0
|
51
|
Impact of erythrocyte species on assays for influenza serology, file e0feeaa7-a190-44d2-e053-6605fe0a8db0
|
48
|
Water and air ozone treatment as an alternative sanitizing technology, file e0feeaa7-a1e8-44d2-e053-6605fe0a8db0
|
37
|
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?, file e0feeaab-cb13-44d2-e053-6605fe0a8db0
|
31
|
Sea buckthorn bud extract displays activity against cell-cultured Influenza virus, file e0feeaa7-e892-44d2-e053-6605fe0a8db0
|
30
|
International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE, file e0feeaa7-e893-44d2-e053-6605fe0a8db0
|
22
|
Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap?, file c9cd0400-a664-4daf-a6e5-7058aa090d7e
|
20
|
SARS-CoV-2 epidemiological trend before vaccination era: a seroprevalence study in Apulia, Southern Italy, in 2020, file da6c62ef-026d-4865-a2eb-94e1df08bb71
|
20
|
Surveillance of Influenza and Other Airborne Transmission Viruses during the 2021/2022 Season in Hospitalized Subjects in Tuscany, Italy, file 6ac9ea98-d9a1-4395-a9bd-c6a02bf73b65
|
19
|
Lower frequency of SARS-CoV-2-associated severe respiratory infections among adults vaccinated against the 2021/22 season influenza, file cf20ec68-3f5e-4a5c-b9ef-e6faa1ea06a3
|
19
|
Epidemiological and virological surveillance of Severe Acute Respiratory Infections in the 2019/2020 season in Siena, Tuscany, Italy, file e0feeaaa-eb33-44d2-e053-6605fe0a8db0
|
17
|
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples, file 90213800-72dc-4cd9-925c-00cc47edff67
|
16
|
CORRELATES OF PROTECTION AND HOST-RELATED MODIFIERS OF THE IMMUNOGENICITY OF INFLUENZA VACCINES: EVIDENCE MAPS AND EVIDENCE GAPS, file e0feeaa9-6b77-44d2-e053-6605fe0a8db0
|
16
|
Detection of antibodies against influenza D virus in swine veterinarians in Italy in 2004, file 42ef957e-b966-4b81-8af7-501177334582
|
15
|
In vitro virucidal activity of mouthwashes on SARS-CoV-2, file a235d0f0-fc48-4470-8c2b-a6fde85c0dc9
|
12
|
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage, file a8f26901-f358-48a2-bfa8-5e2388390e27
|
12
|
Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells, file 22556c95-02d1-4a24-84b1-fab5b2a00ccd
|
11
|
Surveillance of Severe Acute Respiratory Infection and Influenza Vaccine Effectiveness among Hospitalized Italian Adults, 2021/22 Season, file e29cfff2-fbb4-47ba-97f5-e718853d1d0f
|
8
|
How much ozone bactericidal activity is compromised by plasma components?, file e0feeaa5-e1e3-44d2-e053-6605fe0a8db0
|
7
|
Regional and sex inequalities of avoidable mortality in Italy: A time trend analysis, file 0bf2dd9e-d265-49b7-9aee-3e8f859d664c
|
6
|
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection, file 34daf04a-216a-45e0-9932-c04da2c134e3
|
6
|
Correlation of Influenza B Haemagglutination Inhibiton, Single-Radial Haemolysis and Pseudotype-Based Microneutralisation Assays for Immunogenicity Testing of Seasonal Vaccines, file 41b67ca9-de0a-4457-b0da-00b4348c8581
|
6
|
Immunogenicity of Calvenza-03 EIV/EHV® Vaccine in Horses: Comparative In Vivo Study, file 139e3939-bbaf-4da0-94b2-783154373e9b
|
5
|
West Nile Virus Seroprevalence in the Italian Tuscany Region from 2016 to 2019, file d0439d92-e9d9-42d5-8a73-ac4de8e3ec5b
|
5
|
COVID-19 Outbreak and BNT162b2 mRNA Vaccination Coverage in a Correctional Facility during Circulation of the SARS-CoV-2 Omicron BA.1 Variant in Italy, file aed8427f-b2d7-4dcc-83d7-f0ae9de2cb7f
|
4
|
Seroprevalence of antibodies to cytomegalovirus in pregnant women in the Apulia region (Italy), file c507c5cd-2220-47e1-b0ea-fc893d9b75d7
|
4
|
null, file e0feeaa6-3ad2-44d2-e053-6605fe0a8db0
|
4
|
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants, file e0feeaab-40b7-44d2-e053-6605fe0a8db0
|
4
|
Evaluation of immune response to SARS-CoV-2 Omicron sublineages six months after different vaccination regimens in Italy, file 302687b0-568c-4468-a4ec-06210c57ebaf
|
3
|
The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence, file be50ad9f-6ff4-4cde-8595-aeceac72ec09
|
3
|
Tick-borne encephalitis (TBE): an underestimated risk…still: report of the 14th annual meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE), file e0feeaa4-f6c0-44d2-e053-6605fe0a8db0
|
3
|
Swine influenza and vaccines: an alternative approach for decision making about pandemic prevention, file e0feeaa4-fd77-44d2-e053-6605fe0a8db0
|
3
|
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations, file ef3b9d52-0fa0-4c2a-bb67-b47aeb6917d8
|
3
|
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection, file 6a083519-4b20-4fa1-9dfe-49bbc64b3433
|
2
|
Occupational risk for hepatitis B and C among dental staff in the province of Siena (Italy), file e0feeaa4-e9ee-44d2-e053-6605fe0a8db0
|
2
|
Retrospective Study Evaluating Seroprevalence of Hepatitis E Virus in Blood Donors and in Swine Veterinarians in Italy (2004), file e0feeaa6-39e8-44d2-e053-6605fe0a8db0
|
2
|
Flucelvax (Optaflu) for seasonal influenza, file e0feeaa7-a0ea-44d2-e053-6605fe0a8db0
|
2
|
Epidemiology and prevention of Human Papillomavirus, file e0feeaa7-a1d7-44d2-e053-6605fe0a8db0
|
2
|
Establishment and validation of a high-throughput micro-neutralization assay for respiratory syncytial virus (subtypes A and B), file 85ecdd06-716c-4b87-9a12-3cdc7c1a22bb
|
1
|
Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4+ T cell immunity within the FLUCOP consortium, file 88a1cca4-b633-468e-a984-70905543dc53
|
1
|
Descriptive Study on Tuberculosis in Southern Tuscany: hospitalizations at Arezzo's Hospital from 1982 until 1996, file e0feeaa4-c344-44d2-e053-6605fe0a8db0
|
1
|
A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines, file e0feeaa4-cc42-44d2-e053-6605fe0a8db0
|
1
|
Correlates of protection against influenza, file e0feeaa4-d003-44d2-e053-6605fe0a8db0
|
1
|
Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in mice, file e0feeaa4-d47b-44d2-e053-6605fe0a8db0
|
1
|
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production, file e0feeaa4-f45a-44d2-e053-6605fe0a8db0
|
1
|
Tick-borne encephalitis: the impact of epidemiology, changing lifestyle, and environmental factors. Conference report of the 12th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE), file e0feeaa4-f6bd-44d2-e053-6605fe0a8db0
|
1
|
Tick-borne encephalitis: from childhood to golden age does increased mobility mean increased risk? Conference report of the 11th meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE), file e0feeaa4-f6bf-44d2-e053-6605fe0a8db0
|
1
|
Safety and immunogenicity of a subunit influenza vaccine, file e0feeaa4-f6c1-44d2-e053-6605fe0a8db0
|
1
|
Guida alle vaccinazioni in Italia, file e0feeaa4-f6c2-44d2-e053-6605fe0a8db0
|
1
|
Indagini microbiologiche su acque potabili sottoposte a trattamenti domestici di osmosi inversa, file e0feeaa4-f865-44d2-e053-6605fe0a8db0
|
1
|
Correlates of protection against influenza, file e0feeaa4-f95d-44d2-e053-6605fe0a8db0
|
1
|
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison, file e0feeaa5-9838-44d2-e053-6605fe0a8db0
|
1
|
Neisseria meningitidis infection: Who, when and where?, file e0feeaa6-2f94-44d2-e053-6605fe0a8db0
|
1
|
Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children, file e0feeaa6-3453-44d2-e053-6605fe0a8db0
|
1
|
Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination, file e0feeaa6-3621-44d2-e053-6605fe0a8db0
|
1
|
The Safety of Adjuvanted Vaccines Revisited: Vaccine-Induced Narcolepsy, file e0feeaa6-36f7-44d2-e053-6605fe0a8db0
|
1
|
Fighting Neisseria meningitidis: past and current vaccination strategies, file e0feeaa6-3d8a-44d2-e053-6605fe0a8db0
|
1
|
null, file e0feeaa6-553a-44d2-e053-6605fe0a8db0
|
1
|
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2, file e0feeaa6-553c-44d2-e053-6605fe0a8db0
|
1
|
An unwanted guest: Neisseria meningitidis–carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence, file e0feeaa7-a1e6-44d2-e053-6605fe0a8db0
|
1
|
Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses, file e0feeaa7-a24d-44d2-e053-6605fe0a8db0
|
1
|
Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations, file e0feeaa7-a252-44d2-e053-6605fe0a8db0
|
1
|
Medicine use and recurrent complaints among 15-years-old adolescents in Tuscany, file e0feeaa8-1855-44d2-e053-6605fe0a8db0
|
1
|
Low prevalence of antibodies against pertussis in pregnant women in Italy, file e0feeaa8-597e-44d2-e053-6605fe0a8db0
|
1
|
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients, file e0feeaaa-673f-44d2-e053-6605fe0a8db0
|
1
|
Totale |
4.631 |